Regulatory flexibility can make continuous improvement possible.
Tony Lubiniecki
Advertisement
Tony Lubiniecki is the vice president of biopharmaceutical development & marketed product support at Centocor R&D, Inc.
Articles by Tony Lubiniecki
Second in a three-part series that discusses the complexities of QbD implementation in biotech development.
First in a three-part series that discusses the complexities of QbD implementation in biotech product development.
Advertisement
Latest Updated Articles
Quality by Design for Biotechnology Products—Part 3Published: January 1st 2010 | Updated:
Quality by Design for Biotechnology Products—Part 2Published: December 1st 2009 | Updated:
Quality by Design for Biotechnology Products—Part 1Published: November 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
3
Outsourcing Small Molecule Purification Processes
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
